Terms: = Brain cancer AND FGFR1OP, FOP, 11116, ENSG00000213066
20 results:
1. Relations Between Posttraumatic Growth and Fear of Progression Among Young and Middle-Aged Primary brain Tumor Patients: The Parallel Mediating Role of Perceived Social Support and Illness Uncertainty.
Du L; Cai J; Yu J; Chen X; Yang X; Xu X; Zhang X
World Neurosurg; 2024 Apr; 184():e794-e802. PubMed ID: 38364895
[TBL] [Abstract] [Full Text] [Related]
2. Health anxiety and the negative interpretation of children's bodily symptoms in mothers of cancer patients.
Hosseinchi P; Ghalibaf E; Kamyab G; Eghbali A; Khatibi A
J Cancer Surviv; 2024 Feb; 18(1):157-164. PubMed ID: 37470950
[TBL] [Abstract] [Full Text] [Related]
3. Circ
Li J; Ma J; Huang S; Li J; Zhou L; Sun J; Chen L
Mol Cell Biol; 2023; 43(7):354-369. PubMed ID: 37427890
[TBL] [Abstract] [Full Text] [Related]
4. circTOP2A functions as a ceRNA to promote glioma progression by upregulating RPN2.
Sun J; Wang J; Li M; Li S; Li H; Lu Y; Li F; Xin T; Jin F
Cancer Sci; 2023 Feb; 114(2):490-503. PubMed ID: 36227125
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
[TBL] [Abstract] [Full Text] [Related]
6. Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors.
Engers DW; Bollinger SR; Felts AS; Vadukoot AK; Williams CH; Blobaum AL; Lindsley CW; Hong CC; Hopkins CR
Bioorg Med Chem Lett; 2020 Sep; 30(18):127418. PubMed ID: 32750526
[TBL] [Abstract] [Full Text] [Related]
7. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway.
Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889
[TBL] [Abstract] [Full Text] [Related]
8. ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma.
Sekimata K; Sato T; Sakai N
Chem Pharm Bull (Tokyo); 2020; 68(3):194-200. PubMed ID: 32115526
[TBL] [Abstract] [Full Text] [Related]
9. ACVR1 Function in Health and Disease.
Valer JA; Sánchez-de-Diego C; Pimenta-Lopes C; Rosa JL; Ventura F
Cells; 2019 Oct; 8(11):. PubMed ID: 31683698
[No Abstract] [Full Text] [Related]
10. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract] [Full Text] [Related]
11. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract] [Full Text] [Related]
12. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract] [Full Text] [Related]
13. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
[TBL] [Abstract] [Full Text] [Related]
14. RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway.
Sun J; Li B; Jia Z; Zhang A; Wang G; Chen Z; Shang Z; Zhang C; Cui J; Yang W
J Neurooncol; 2018 Oct; 140(1):15-26. PubMed ID: 29916101
[TBL] [Abstract] [Full Text] [Related]
15. Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.
Machiya A; Tsukamoto S; Ohte S; Kuratani M; Fujimoto M; Kumagai K; Osawa K; Suda N; Bullock AN; Katagiri T
Bone; 2018 Jun; 111():101-108. PubMed ID: 29551750
[TBL] [Abstract] [Full Text] [Related]
16. Shared ACVR1 mutations in fop and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases.
Han HJ; Jain P; Resnick AC
Bone; 2018 Apr; 109():91-100. PubMed ID: 28780023
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma Cells.
Huang W; Zhang C; Cui M; Niu J; Ding W
Anticancer Res; 2017 Aug; 37(8):4285-4294. PubMed ID: 28739720
[TBL] [Abstract] [Full Text] [Related]
18. Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.
Pacifici M; Shore EM
Cytokine Growth Factor Rev; 2016 Feb; 27():93-104. PubMed ID: 26776312
[TBL] [Abstract] [Full Text] [Related]
19. ACVR1 mutations in DIPG: lessons learned from fop.
Taylor KR; Vinci M; Bullock AN; Jones C
Cancer Res; 2014 Sep; 74(17):4565-70. PubMed ID: 25136070
[TBL] [Abstract] [Full Text] [Related]
20. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.
Taylor KR; Mackay A; Truffaux N; Butterfield Y; Morozova O; Philippe C; Castel D; Grasso CS; Vinci M; Carvalho D; Carcaboso AM; de Torres C; Cruz O; Mora J; Entz-Werle N; Ingram WJ; Monje M; Hargrave D; Bullock AN; Puget S; Yip S; Jones C; Grill J
Nat Genet; 2014 May; 46(5):457-461. PubMed ID: 24705252
[TBL] [Abstract] [Full Text] [Related]